BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 28453520)

  • 1. WDR23 regulates NRF2 independently of KEAP1.
    Lo JY; Spatola BN; Curran SP
    PLoS Genet; 2017 Apr; 13(4):e1006762. PubMed ID: 28453520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sp1 is a substrate of Keap1 and regulates the activity of CRL4A
    Siswanto FM; Oguro A; Imaoka S
    J Biol Chem; 2021; 296():100704. PubMed ID: 33895141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. WDR23 regulates the expression of Nrf2-driven drug-metabolizing enzymes.
    Siswanto FM; Oguro A; Arase S; Imaoka S
    Drug Metab Pharmacokinet; 2020 Oct; 35(5):441-455. PubMed ID: 32839090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kelch-like ECH-associated protein 1 (KEAP1) differentially regulates nuclear factor erythroid-2-related factors 1 and 2 (NRF1 and NRF2).
    Tian W; Rojo de la Vega M; Schmidlin CJ; Ooi A; Zhang DD
    J Biol Chem; 2018 Feb; 293(6):2029-2040. PubMed ID: 29255090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene-expression signature regulated by the KEAP1-NRF2-CUL3 axis is associated with a poor prognosis in head and neck squamous cell cancer.
    Namani A; Matiur Rahaman M; Chen M; Tang X
    BMC Cancer; 2018 Jan; 18(1):46. PubMed ID: 29306329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evolutionary conserved N-terminal domain of Nrf2 is essential for the Keap1-mediated degradation of the protein by proteasome.
    Katoh Y; Iida K; Kang MI; Kobayashi A; Mizukami M; Tong KI; McMahon M; Hayes JD; Itoh K; Yamamoto M
    Arch Biochem Biophys; 2005 Jan; 433(2):342-50. PubMed ID: 15581590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chlorogenic Acid Activates Nrf2/SKN-1 and Prolongs the Lifespan of Caenorhabditis elegans via the Akt-FOXO3/DAF16a-DDB1 Pathway and Activation of DAF16f.
    Siswanto FM; Sakuma R; Oguro A; Imaoka S
    J Gerontol A Biol Sci Med Sci; 2022 Aug; 77(8):1503-1516. PubMed ID: 35279029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer related mutations in NRF2 impair its recognition by Keap1-Cul3 E3 ligase and promote malignancy.
    Shibata T; Ohta T; Tong KI; Kokubu A; Odogawa R; Tsuta K; Asamura H; Yamamoto M; Hirohashi S
    Proc Natl Acad Sci U S A; 2008 Sep; 105(36):13568-73. PubMed ID: 18757741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of the Nrf2-Keap1 antioxidant response by the ubiquitin proteasome system: an insight into cullin-ring ubiquitin ligases.
    Villeneuve NF; Lau A; Zhang DD
    Antioxid Redox Signal; 2010 Dec; 13(11):1699-712. PubMed ID: 20486766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NRF2 DLG Domain Mutations Identified in Japanese Liver Cancer Patients Affect the Transcriptional Activity in HCC Cell Lines.
    Haque E; Śmiech M; Łuczyńska K; Bouchard MF; Viger R; Kono H; Pierzchała M; Taniguchi H
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34069882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zinc-binding triggers a conformational-switch in the cullin-3 substrate adaptor protein KEAP1 that controls transcription factor NRF2.
    McMahon M; Swift SR; Hayes JD
    Toxicol Appl Pharmacol; 2018 Dec; 360():45-57. PubMed ID: 30261176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular mechanisms of the Keap1–Nrf2 pathway in stress response and cancer evolution.
    Taguchi K; Motohashi H; Yamamoto M
    Genes Cells; 2011 Feb; 16(2):123-40. PubMed ID: 21251164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absolute Amounts and Status of the Nrf2-Keap1-Cul3 Complex within Cells.
    Iso T; Suzuki T; Baird L; Yamamoto M
    Mol Cell Biol; 2016 Dec; 36(24):3100-3112. PubMed ID: 27697860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Naturally-Occurring Dominant-Negative Inhibitor of Keap1 Competitively against Its Negative Regulation of Nrf2.
    Qiu L; Wang M; Zhu Y; Xiang Y; Zhang Y
    Int J Mol Sci; 2018 Jul; 19(8):. PubMed ID: 30042301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. iASPP Is an Antioxidative Factor and Drives Cancer Growth and Drug Resistance by Competing with Nrf2 for Keap1 Binding.
    Ge W; Zhao K; Wang X; Li H; Yu M; He M; Xue X; Zhu Y; Zhang C; Cheng Y; Jiang S; Hu Y
    Cancer Cell; 2017 Nov; 32(5):561-573.e6. PubMed ID: 29033244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Keap1 recruits Neh2 through binding to ETGE and DLG motifs: characterization of the two-site molecular recognition model.
    Tong KI; Katoh Y; Kusunoki H; Itoh K; Tanaka T; Yamamoto M
    Mol Cell Biol; 2006 Apr; 26(8):2887-900. PubMed ID: 16581765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dysfunctional KEAP1-NRF2 interaction in non-small-cell lung cancer.
    Singh A; Misra V; Thimmulappa RK; Lee H; Ames S; Hoque MO; Herman JG; Baylin SB; Sidransky D; Gabrielson E; Brock MV; Biswal S
    PLoS Med; 2006 Oct; 3(10):e420. PubMed ID: 17020408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Keap1-Nrf2 system as an in vivo sensor for electrophiles.
    Uruno A; Motohashi H
    Nitric Oxide; 2011 Aug; 25(2):153-60. PubMed ID: 21385624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p97 Negatively Regulates NRF2 by Extracting Ubiquitylated NRF2 from the KEAP1-CUL3 E3 Complex.
    Tao S; Liu P; Luo G; Rojo de la Vega M; Chen H; Wu T; Tillotson J; Chapman E; Zhang DD
    Mol Cell Biol; 2017 Apr; 37(8):. PubMed ID: 28115426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular Basis of the KEAP1-NRF2 Signaling Pathway.
    Suzuki T; Takahashi J; Yamamoto M
    Mol Cells; 2023 Mar; 46(3):133-141. PubMed ID: 36994473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.